PCSK9 gene mutations and low-density lipoprotein cholesterol.

Abstract excerpt

Proprotein convertase subtilisin-like/kexin type 9 (PCSK9) is a newly-identified circulating protein in cholesterol metabolism in mammals, including humans, which has emerged as a new pharmacological target for hypocholesterolemia. It has been demonstrated that PCSK9 gene mutations are associated with hyper- or hypocholesterolemia. In the latter case, the incidence of coronary heart disease (CHD) is markedly...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cholesterol, LDL
• Share to LDLR gene
• Share to PCSK9 gene